Articles

Reflections on eyeforpharma Barcelona: making the most of every conver…

2nd April 2015

Reflections on eyeforpharma Barcelona: making the most of every conversationPaul Tunnah, with commentary from Craig Fiebig

Returning from last week's eyeforpharma Barcelona event on pharmaceutical industry commercial engagement, Paul Tunnah considers the challenges it raises and some parallels with the world outside healthcare, in speaking with... Read more

7 Questions: Digital healthcare & technology

1st April 2015

7 Questions: Digital healthcare & technologyDenise Silber

pharmaphorum spoke to digital health strategist and influencer Denise Silber about how and where technology is, and will be, affecting the healthcare environment.What is your involvement in digital healthcare/healthcare technology?There... Read more

Data protection laws must not block vital healthcare research

31st March 2015

Data protection laws must not block vital healthcare researchSascha Marschang

Sascha Marschang, Policy Manager for Health Systems, European Public Health Alliance (EPHA) argues that proposed restrictions on using health data could prevent many hugely beneficial studies being conducted in Europe.New... Read more

Antibiotic resistance: alarm bells ring louder than ever

30th March 2015

Antibiotic resistance: alarm bells ring louder than everChristophe Homer

Though international focus is turning to antimicrobial resistance and incentives are being provided for research into new drugs, there are many hurdles to be jumped before a blockbuster can be... Read more

News

Bowel Cancer UK launches ambitious research goals

1st April 2015

Bowel Cancer UK launches ambitious research goalsAndrew McConaghie

Bowel Cancer UK has unveiled plans to become the UK's leading research and campaigning charity dedicated to stopping bowel cancer for good.The charity says it wants to be bold and... Read more

CHMP backs new cancer, diabetes drugs

1st April 2015

CHMP backs new cancer, diabetes drugsStaff reporter

A combination diabetes drug from Boehringer Ingelheim/Lilly and a treatment for a rare form of thyroid cancer from Eisai head the list of new drugs backed for approval in Europe... Read more

Amgen’s Kyprolis set to muscle in on myeloma

1st April 2015

Amgen’s Kyprolis set to muscle in on myelomaAndrew McConaghie

Amgen could soon have approval for its drug Kyprolis as a second line treatment in multiple myeloma, a therapy area currently being dominated by Celgene.The FDA has fast-tracked its review... Read more

Teva and Horizon acquisitions maintain sector spree

31st March 2015

Teva and Horizon acquisitions maintain sector spreeAndrew McConaghie

The pharma sector's run of merger and acquisitions continues, with two new deals worth $1 billion-plus from Teva and Horizon announced yesterday.While the announcements weren't among the biggest, they show... Read more

Audio & Video

Being Patient-centric is being Family-ce…

 

Cancer survivor and patient opinion leader Andrew Schorr and his wife Esther Schorr discuss how families should be involved in decision-making around care for patients.... View more

On demand webinar: Staring into the aby…

IMS webinar image 300x200

 

Regardless of the colour of the next UK government that emerges as a result of the May election, the £30–50bn NHS... View more

Live Tweetchat: Managing COPD in the rea…

Tweetchat-600x400a

Working in partnership, Atlantis Healthcare and pharmaphorum present a Tweetchat focussed on the real world challenges patients face in managing their COPD,... View more

Live webinar/debate - Feb 4th - COPD, co…

Join the COPD webinar/debate

 

 

COPD is a widespread, costly and largely preventable condition which affects over 300 million people worldwide and is recognised... View more

White Papers

Optimising patient outcomes through phys…

Optimising patient outcomes through physician educationAnita Seaford

Physician education is undergoing a massive change as the volume of advances in therapies and practices increases and the use of digital channels facilitates new forms of scientific exchange. This white... View info

Is pharma brand marketing dead?

Is pharma brand marketing dead?Mark Sales, Fabrice Bourg & Richard Goosey

This comprehensive supplement brings together a series of articles, insights and discussions produced by Kantar Health in order to help stimulate debate and fresh thinking about the future of pharmaceutical... View info

Improved health and wellbeing in COPD

Improved health and wellbeing in COPDAna Maria Arboleda, Clare Maloney & Prof John Weinman

Chronic obstructive pulmonary disease (COPD) is a progressive and debilitating disorder, which, as it progresses, places a significant burden on individuals and those caring for them. This is not only... View info

Computer Gaming: The Future of Decision-…

Computer Gaming: The Future of Decision-Making for Life Sciences?

How can life science brands identify winning strategic decisions when there are so many variables to consider? One route is via 'road-testing' decisions ahead of sign-off under computer game simulated... View info

Further News & Articles

Deal agreed at last on GSK's Bexsero in UK

After months of delay, GlaxoSmithKline has agreed a deal with the UK government that will allow its meningiti... Read more

News

Novartis drug gets 'Promising Innovative Medicine' status in UK

Novartis's cancer drug Zykadia has become one of the first drugs to snag Promising Innovation Medicine status in... Read more

News

Twitter raises Periscope to sink rival Meerkat

Twitter has officially launched its new video streaming service Periscope in direct opposition to the recently-i... Read more

News

Advanced manufacturing could ‘transform’ biologics development

Pharma company UCB is part of a consortium which has won UK government funding to help develop next-generation a... Read more

News

Community vital in mHealth

Though the numbers of health and fitness devices are increasing rapidly, empowering users to record and monitor t... Read more

Articles